RIO DE JANEIRO, BRAZIL - The year 2020 can be considered the beginning of the development of the medical cannabis sector in Brazil. Although health regulatory agency Anvisa has allowed the online purchase via import of the substance cannabidiol since 2015, it was only last year that pharmaceutical companies could apply to the agency for a permit to sell in pharmacies and process the cannabis derivative in domestic facilities.
Read also: Check out our coverage on cannabis in Brazil
At the moment, only Paraná pharmaceutical company Prati-Donaduzzi . . .